Retatrutide 20mg

Description

Retatrutide 20mg is a higher-dosed triple agonist peptide that acts on the GLP-1, GIP, and glucagon receptors. This advanced incretin compound is being researched for its enhanced effects on metabolic optimization, glucose regulation, and body fat reduction. By stimulating multiple metabolic pathways, Retatrutide 20mg supports energy expenditure, insulin sensitivity, and may play a role in improving weight management and muscle preservation during caloric deficit research models.

Scientific Information:

• Receptor Activity: GIP / GLP-1 / Glucagon receptor agonist

For Research Use Only. Not for Human Consumption